NTRA
Natera, Inc.Company Information
- Company Name
- Natera, Inc.
- CIK
- CIK0001604821
- Category
- Large accelerated filer
- Ticker: Exchange
- NTRA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- NTRA
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-06-24
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 966,592
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 100,612,893
- Shares outstanding
- 141,502,000
- Ownership
- 71.10%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- 1.29%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1,092 | 1,088 | 1,076 | 1,041 | 1,000 | 974 | 946 | 893 | 797 | 814 | 642 | 669 | ||||||
| Marketable Securities Current | - | - | - | 1 | 16 | 18 | 23 | 29 | 90 | 69 | 237 | 268 | ||||||
| Accounts Receivable Net Current | 422 | 418 | 297 | 286 | 309 | 318 | 314 | 307 | 336 | 289 | 278 | 255 | ||||||
| Inventory Net | 80 | 71 | 68 | 65 | 54 | 50 | 45 | 49 | 41 | 43 | 41 | 42 | ||||||
| Prepaid Expense And Other Assets Current | 65 | 76 | 56 | 54 | 52 | 56 | 49 | 45 | 38 | 47 | 61 | 33 | ||||||
| Assets Current | 1,659 | 1,652 | 1,497 | 1,447 | 1,432 | 1,416 | 1,376 | 1,323 | 1,302 | 1,261 | 1,259 | 1,267 | ||||||
| Property Plant And Equipment Net | 318 | 269 | 241 | 206 | 189 | 180 | 162 | 142 | 133 | 126 | 111 | 105 | ||||||
| Operating Lease Right Of Use Asset | 130 | 134 | 109 | 97 | 95 | 95 | 86 | 88 | 53 | 55 | 57 | 58 | ||||||
| Goodwill | 141 | 141 | 141 | - | - | - | - | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 360 | 367 | 374 | - | - | - | 11 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 50 | 51 | 37 | 71 | 41 | 41 | 26 | 38 | 29 | 26 | 15 | 16 | ||||||
| Assets | 2,657 | 2,614 | 2,398 | 1,821 | 1,757 | 1,732 | 1,661 | 1,591 | 1,517 | 1,468 | 1,442 | 1,447 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 75 | 62 | 33 | 46 | 37 | 39 | 35 | 28 | 33 | 26 | 15 | 21 | ||||||
| Employee Related Liabilities Current | 106 | 144 | 93 | 77 | 55 | 47 | 62 | 49 | 41 | 40 | 46 | 39 | ||||||
| Business Combination Contingent Consideration Liability Current | 23 | 22 | 22 | - | - | - | - | - | - | - | - | - | ||||||
| Contract With Customer Liability Current | 41 | 37 | 25 | 22 | 22 | 21 | 20 | 18 | 18 | 18 | 17 | 15 | ||||||
| Short Term Borrowings | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | ||||||
| Other Liabilities Current | 228 | 213 | 189 | 216 | 191 | 178 | 147 | 126 | 141 | 142 | 149 | 134 | ||||||
| Liabilities Current | 553 | 558 | 441 | 442 | 385 | 366 | 344 | 301 | 315 | 306 | 307 | 290 | ||||||
| Long Term Notes And Loans | - | - | - | - | - | - | - | 287 | 284 | 283 | 283 | 283 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 98 | 103 | 97 | - | - | - | - | - | - | - | - | - | ||||||
| Deferred Tax And Other Liabilities Noncurrent | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 143 | 145 | 118 | 104 | 103 | 103 | 97 | 99 | 61 | 64 | 67 | 68 | ||||||
| Contract With Customer Liability Noncurrent | 16 | 17 | 17 | - | - | - | 17 | - | - | - | 19 | 21 | ||||||
| Other Liabilities Noncurrent | 25 | 16 | 12 | - | - | - | 8 | - | - | - | - | - | ||||||
| Liabilities | 836 | 840 | 686 | 569 | 511 | 493 | 465 | 712 | 680 | 674 | 676 | 662 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 4,750 | 4,635 | 4,489 | 4,076 | 3,982 | 3,875 | 3,764 | 3,393 | 3,320 | 3,241 | 3,146 | 3,089 | ||||||
| Retained Earnings Accumulated Deficit | -2,928 | -2,861 | -2,776 | -2,823 | -2,736 | -2,635 | -2,568 | -2,514 | -2,482 | -2,445 | -2,377 | -2,299 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -2 | -3 | -5 | ||||||
| Stockholders Equity | 1,821 | 1,774 | 1,712 | 1,252 | 1,246 | 1,240 | 1,195 | 879 | 837 | 794 | 765 | 785 | ||||||
| Liabilities And Stockholders Equity | 2,657 | 2,614 | 2,398 | 1,821 | 1,757 | 1,732 | 1,661 | 1,591 | 1,517 | 1,468 | 1,442 | 1,447 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 7 | 8 | 8 | 8 | 8 | 7 | 7 | 6 | 7 | 7 | 6 | 6 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | ||||||
| Common Stock Shares Issued | 144 | 143 | 140 | 138 | 137 | 136 | 133 | 124 | 123 | 122 | 120 | 119 | ||||||
| Shares Outstanding | 144 | 143 | 140 | 138 | 137 | 136 | 133 | 124 | 123 | 122 | 120 | 119 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNatera, Inc. (NTRA) — SEC Financial Statements & Analysis
Natera, Inc. (NTRA) is a services-medical laboratories company, incorporated in DE. Natera, Inc. trades on Nasdaq as: NTRA. Natera, Inc. (NTRA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, Natera, Inc. carries a market cap of $38.89B, a P/E ratio of -202.20x, a P/B ratio of 21.35x, a P/S ratio of 14.37x, an enterprise value of $37.88B, and an EV/EBITDA multiple of -159.84x. On profitability, it posts a gross margin of 93.26%, an operating margin of -10.70%, a net margin of -7.11%, a Return on Equity (ROE) of -12.54%, a Return on Assets (ROA) of -8.71%, and a Return on Invested Capital (ROIC) of -47.09%. Per share, it reports EPS of $-1.34, diluted EPS of $-1.34, free cash flow per share of $0.59, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 37.82% year-over-year, net income growth of -24.05% year-over-year, and EPS growth of -27.70% year-over-year. On the balance sheet, it maintains a current ratio of 3.00x, a quick ratio of 2.74x, working capital of $1.11B, a debt-to-equity ratio of 0.46x, a debt ratio of 0.31, an interest coverage ratio of -75.89x, free cash flow of $84.20M (TTM), and net debt of $-1.01B. Figures sourced from SEC EDGAR.
- Market Cap
- $38.89B
- P/E TTM
- -202.20x
- EPS TTM
- $-1.34
- P/B TTM
- 21.35x
- ROE TTM
- -12.54%
- ROA TTM
- -8.71%
- Debt To Equity
- 0.46x
- Free Cash Flow TTM
- $84.20M
- Net Revenue TTM Growth 1Y
- 37.82%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Natera, Inc. in?
Natera, Inc. (NTRA) operates in the Services-Medical Laboratories industry.
What exchange does NTRA trade on?
Natera, Inc. (NTRA) trades on the Nasdaq.
Where is Natera, Inc. incorporated?
Natera, Inc. is incorporated in DE.
When was Natera, Inc. (NTRA)'s most recent SEC filing?
Natera, Inc. (NTRA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is NTRA's market cap?
Natera, Inc. (NTRA) has a market capitalization of $38.89B as of 2026-06-30.
What is NTRA's EPS (earnings per share)?
Natera, Inc. (NTRA)'s trailing twelve month EPS is $-1.34 as of 2026-06-30.
What is NTRA's ROE (return on equity)?
Natera, Inc. (NTRA)'s trailing twelve month Return on Equity (ROE) is -12.54% as of 2026-06-30.
What is NTRA's ROA (return on assets)?
Natera, Inc. (NTRA)'s trailing twelve month Return on Assets (ROA) is -8.71% as of 2026-06-30.
What is NTRA's ROIC (return on invested capital)?
Natera, Inc. (NTRA)'s trailing twelve month Return on Invested Capital (ROIC) is -47.09% as of 2026-06-30.
What is NTRA's EV/EBITDA?
Natera, Inc. (NTRA)'s trailing twelve month EV/EBITDA is -159.84x as of 2026-06-30.